InspireMD to price public offering of stock, warrants via Dawson James

Proceeds to be used to conduct sales activities, for corporate purposes

By Angela McDaniels

Tacoma, Wash., March 15 – InspireMD, Inc. plans to price a public offering of common stock and warrants. Dawson James Securities, Inc. is the bookrunner.

Proceeds will be used to conduct sales activities and for general corporate purposes, according to a company news release.

The company’s stock closed at $0.81 (NYSE MKT: NSPR) on Tuesday, and its market cap is $6.31 million.

InspireMD is a medical device company based in Boston.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.